StockData
Novo Nordisk A S logo

Novo Nordisk A S (NVO) stock

NVONYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NONOF
Financials through fiscal 2025, year ended Dec 31, 2025Score 4/30
$39.43−1.27 (-3.12%)

Close on Nov 18, 2026Market cap $176.06BP/E 11.6Yield –

Novo Nordisk A S pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Novo Nordisk A S's pe ratio was 12.0× on Nov 11, 2026, against 14.0× a year earlier. Over the last 5 years it ranged from 10.3× to 67.3×, with a median of 38.2×.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202612.0×−2.4
2025Dec 31, 202514.3×−19.0
2024Dec 31, 202433.3×−23.8
2023Dec 29, 202357.0×+11.7
2022Dec 30, 202245.4×+4.5
2021Dec 31, 202140.9×+14.9
2020Dec 31, 202025.9×+1.8
2019Dec 31, 201924.2×+4.7
2018Dec 31, 201819.5×−2.7
2017Dec 29, 201722.2×+3.5
2016Dec 30, 201618.7×–

More Novo Nordisk A S figures

See a number that looks wrong?